PwC Insights: Five Key Trends Shaping the Future of the Medical Robotics Industry
At the World Medical Robot Conference, Xing Liping, a management consultant in the healthcare sector at PwC China, used data to illustrate global market value trends for medical robots: from USD 2.6 billion in 2014 to a projected USD 7.6 billion by 2020. More aggressive estimates suggest market demand could reach USD 10 billion. According to reports from the China Food and Drug Administration (CFDA), the number of robotic-assisted surgical procedures rose from 25,000 in 2005 to 650,000. Notably, 80% of prostatectomies are performed using robotic systems.
China has also seen continuous innovation and research in the field of robotics, particularly with a surge in domestic medical robots since 2015, including applications in minimally invasive and laparoscopic surgery. Internationally, major U.S. medical device companies are collaborating with Indian partners on the development of new robotic systems, which were expected to enter the market in 2018. Israeli companies have also been actively investing and expanding in this sector. The overall market trend indicates tremendous potential for the medical robotics market!
Given that China’s medical device research and development is still in a developmental stage, our current regulatory oversight is more stringent than that of the United States.
In terms of classification, China and the United States have very similar definitions for medical robotic devices. However, surgical robots are classified as Class II medical devices in the United States, whereas they are categorized as Class III medical devices in China. Additionally, China imposes stricter approval criteria and regulatory oversight for such medical devices compared to the United States.
Regarding the approval cycle, because China assigns a higher classification level to medical robots, the registration and approval timeline for medical robots intended for marketing and sales is significantly longer than that in the United States. Meanwhile, China imposes validity period requirements on medical devices approved for marketing and sales; upon expiration of this period, re-registration and approval with the China Food and Drug Administration (CFDA) are required. The United States has no similar requirement.
Finally, regarding clinical trial requirements, China mandates clinical trials for all Class II and Class III medical devices, whereas the United States requires clinical trials only for a subset of Class II devices. Therefore, companies operating in this industry must familiarize themselves with Chinese regulatory frameworks while learning from advanced U.S. technologies.
We are all aware of this trend; let us examine the specific data to understand the exact figures. The rise in demand is primarily driven by population aging. The global population aged 60 and above is projected to grow by 56%. As this demographic expands, it will continuously generate new and evolving demands for rehabilitation services. According to reports on global population aging, by 2030, the number of individuals aged 60 and older will not only grow at a rate of 5–6% but may also surpass the total number of children aged 0–9. By 2050, the elderly population is likely to exceed the combined total of young people aged 10–20.
Turning to the supply side, the global shortage of healthcare personnel is projected to reach 12.9 million by 2035. To address this growing gap in workforce demand, future solutions will likely rely more heavily on technological innovations, particularly medical robots, to help mitigate the shortfall.
According to the Trading Economics forecasting model, per capita disposable income in China is projected to increase by 41% by 2020, compared with a 15% rise in the United States. This growth in income will drive demand for high-quality healthcare services. Medical robots offer distinct advantages, including minimal bleeding, greater precision, and faster recovery. As noted by academicians from both China and the United States, the rate of medical incidents involving surgical robots is even lower than the probability of aviation accidents, which will gradually foster public acceptance of surgical robotic systems.
Common medical robots are categorized into four types: surgical robots, rehabilitation robots, assistive robots, and service robots.
Currently, there are three mainstream categories of surgical robot applications. The first category includes systems like the da Vinci Surgical System, which performs many complex procedures through minimally invasive techniques. Under surgeon control, these systems enhance precision and improve surgical outcomes. The second category comprises radiosurgery robots, which also prioritize precision by accurately targeting lesion areas. This helps avoid excessive radiation doses or unintended irradiation of healthy tissues caused by hand tremors or inaccurate aiming during manual procedures. Data indicate that such robotic systems can achieve sub-millimeter accuracy, precisely directing radiation to the intended target while minimizing collateral damage. The third category consists of surgical assistance systems, which utilize navigation devices to enhance surgical precision and optimize operative results.
Regarding the application of rehabilitation robots, we observe three primary categories. The first category, exemplified by ReWalk, utilizes sensors and monitors to enable users to stand and walk. The second category employs bioelectric sensors, emphasizing seamless integration with the human body. The third category comprises three modes: FirstStep, ActiveStep, and ProStep. In ActiveStep mode, users can autonomously control the rehabilitation robot, facilitating more effective rehabilitative training. ProStep mode relies primarily on automatic sensing; it detects the user’s bodily movements and uses this feedback to make corrections and trigger subsequent actions.
Assistive robots are primarily categorized into two types. The first type is personal care robots, many of which monitor patients’ health conditions and interact with hospitals after discharge. The second type includes advanced therapeutic robots such as PARO, which facilitate treatment for dementia, Alzheimer’s disease, and cognitive impairments through perceptual interaction, incorporating augmented reality (AR) technology.
In the United States, service applications fall into two main categories. The first is sterilization and disinfection robots, which are predominantly used in healthcare facilities. By operating continuously, these robots enhance the overall sterilization and disinfection efficacy within institutions. Cross-infection rates in healthcare settings are significant; statistical data indicate that approximately one in nine hospital patients previously experienced cross-infection. Deploying sterilization and disinfection robots can intensify pathogen elimination, thereby mitigating cross-infection risks, optimizing the overall hospital environment, and improving comprehensive health management or rehabilitation outcomes. The second category comprises transport robots, which handle routine tasks to reduce the workload of healthcare personnel.
The first is the system, which places greater emphasis on integration, as well as the formalization and standardization of the entire system and model. This includes data integration and how big data applications interact, which will be indispensable in the future. Chronic diseases and sub-health conditions constitute a significant portion of this landscape. These areas are better addressed through systematic management approaches that transform services into a cohesive, organic whole.
The second aspect is interaction, which emphasizes bidirectional human-machine engagement achieved through haptic feedback. This approach aims to enhance the sense of presence and realism. Some experts have raised concerns about whether deviations could lead to misjudgment, an issue that must also be addressed at the interaction level. Currently, the most effective method is to employ inverse feedback mechanisms.
The third aspect concerns structural design, focusing on how materials and assembly methods can achieve lightweight, robust, and agile construction. Additionally, the design must be more energy-efficient, less prone to causing physiological rejection, more miniaturized, and cost-effective. Ultimately, a balance must be struck among safety, quality, and precision, which is a key challenge to address for future sustainable development.
Category 4: Perception. By leveraging interactive multi-models, 3D sensing, or other technical approaches, recognition accuracy is enhanced. Furthermore, through integration—particularly with augmented reality (AR)—objects and environments can be identified. This improved recognition enables robots to execute more precise actions and responses.
Category 5: Cognition, entirely from an AR perspective, focusing on technical applications, machine cognitive capabilities, and learning abilities. This also encompasses knowledge cognition, reasoning, modality, situational awareness, morphology, and more. Cognitive algorithms will enable robots to collaborate with physicians and predict their actions. During interactions, high-resolution sensors will provide visual feedback during surgical procedures, thereby enhancing precision.
Puhua’s insights are derived from global accumulation and synthesis. Meanwhile, Puhua’s clients are leaders in the medical robotics field or command significant market scale; it is through long-term collaboration with these clients that Puhua has gained a comprehensive understanding of overall trends and development directions.